However, no differences were observed between the more aggressive DLBCL cases when compared to the more indolent FL cases, not forming a parallel between lowered CAV1 expression being associated with a more aggressive disease in both breast [23] and prostate cancer [24]. This evidence concerns the gene CAV1 and diffuse large B-cell lymphoma.